Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eton Pharmaceuticals, Inc. - Common Stock (NQ:ETON)

16.00 -0.70 (-4.19%)
Streaming Delayed Price Updated: 12:29 PM EST, Dec 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eton Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023 ↗
ETON stock results show that Eton Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Recap: Eton Pharmaceuticals Q4 Earnings ↗
 
Via Benzinga
News headline image
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Why the growth investor may take a look at NASDAQ:ETON. ↗
Exploring ETON PHARMACEUTICALS INC (NASDAQ:ETON)'s growth characteristics. 
Via Chartmill
News headline image
Evaluating NASDAQ:ETON for Growth Investment Opportunities. ↗
Exploring ETON PHARMACEUTICALS INC (NASDAQ:ETON)'s growth characteristics. 
Via Chartmill
News headline image
Eton Pharmaceuticals: Q3 Earnings Insights ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 14, 2024 ↗
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. 
Via Benzinga
News headline image
Eton Pharmaceuticals Earnings Preview ↗
 
Via Benzinga
News headline image
Is NASDAQ:ETON suited for growth investing? ↗
ETON PHARMACEUTICALS INC (NASDAQ:ETON) may be suited for growth investing, we'll explore why in this article. 
Via Chartmill
News headline image
Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Gilead Sciences Tops Q3 Earnings And Revenue Estimates ↗
While Gilead has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? 
Via Talk Markets
News headline image
Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy. 
Via Benzinga
Topics Bankruptcy
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Consolidated Water, Spectrum Brands, Arco Platform, Semler Scientific And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
News headline image
FSR Stock Alert: What to Know About the New Fisker Ronin EV ↗
Fisker (FSR) stock is in the news Friday after the company provided customers with more details about the upcoming Fisker Ronin Super GT EV. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Is Cano Health (CANO) Stock Down 48% Today? ↗
Cano Health (CANO) stock is taking a beating on Friday after the healthcare company provided a business update in its latest earnings report. 
Via InvestorPlace
News headline image
Why is Yield10 Bioscience (YTEN) Stock Down 46% Today? ↗
Yield10 Bioscience (YTEN) stock is falling hard on Friday with heavy trading after a public share offering went into effect. 
Via InvestorPlace
News headline image
Why Semler Scientific Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket ↗
Gainers Amyris, Inc. (NASDAQ: AMRS) shares surged 45.4% to $0.0958 in pre-market trading. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy. 
Via Benzinga
Topics Bankruptcy
News headline image
Why Is Eton Pharmaceuticals (ETON) Stock Up 30% Today? ↗
Eton Pharmaceuticals (ETON) stock is soaring following the release of its earnings report for the second quarter of 2023! 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.